Purpose Rotator cuff injuries are associated with atrophy and fat infiltration into the muscle, commonly referred to as Bfatty degeneration.^As the poor function of chronically torn muscles may limit recovery after surgical repair, there is considerable interest in finding therapies to enhance muscle regeneration. Stromal vascular fraction stem cells (SVFCs) can improve muscle regeneration in other chronic injury states, and our objective was to evaluate the ability of SVFCs to reduce fibrosis and fat accumulation, and enhance muscle fibre specific force production after chronic rotator cuff tear. Methods Chronic supraspinatus tears were induced in adult immunodeficient rats, and repaired one month following tear. Rats received vehicle control, or injections of 3×10 5 or 3×10 6 human SVFCs into supraspinatus muscles. Results Two weeks following repair, we detected donor human DNA and protein in SVFC treated muscles. There was a 40 % reduction in fibrosis in the treated groups compared to controls (p=0.03 for 3×10 5 , p=0.04 for 3×10 6 ), and no differences between groups for lipid content or force production were observed.
Introduction
Large rotator cuff tears are often associated with fibrosis, muscle atrophy, and inter-and intra-muscular fat infiltration, commonly referred to as Bfatty degeneration.^Surgical repair of torn rotator cuff muscles does not reverse fatty degeneration, and due to the shortening of the muscle that occurs in chronic tears, as much as 90 % of muscle fibres can be injured at the time of surgical repair [1] . This massive second injury induced by repair can lead to additional lipid infiltration and fibrosis which can further limit tissue regeneration and prevent full recovery [1, 2] . The fibrosis that commonly occurs in injured muscles increases the passive stiffness of the extracellular matrix (ECM), and can also disrupt the lateral transmission of forces between muscle fibers, causing increased shearing and damage of muscle fibre membranes [3] . The combination of increased tissue stiffness and disrupted lateral force transmission can greatly increase the susceptibility of the muscle to further injury and re-tear, complicate rehabilitation, and prevent the full restoration of function [4] .
Mesenchymal stem cells (MSCs) are a pluripotent population of adult stem cells found in various compartments across the body, and can give rise to a diverse lineage of differentiated cell types [5] . In addition to serving as progenitor cells, MSCs can secrete growth factors that function in a paracrine fashion to enhance tissue regeneration [5] . The stromal vascular fraction (SVF) of adipose tissue is highly enriched with a population of endothelial progenitor cells and adipose derived stem cells, which are a subclass of MSCs [6] . SVF cells (SVFCs) can be easily obtained from lipoaspirates of subcutaneous adipose tissue, and several studies have demonstrated these cells can promote tissue regeneration and prevent fibrosis after injury or disease [6, 7] . Given the therapeutic potential of SVFCs and the relative ease at which they can be obtained, our objective was to evaluate the ability of SVFCs to prevent fibrosis and enhance muscle regeneration following chronic rotator cuff tear. We hypothesized that administration of human SVFCs into the chronically torn supraspinatus muscles of immunodeficient rats would reduce fibrosis and fat accumulation, and enhance muscle fiber force production. To test this hypothesis, we obtained SVFCs using a point-of-care isolation system, administered cells to the chronically torn muscles of immunodeficient rats, and measured changes in supraspinatus muscle collagen content, contractility, and lipid accumulation two weeks after administering SVFCs.
Methods
Animals This study was approved by the University of Michigan Committee for the Use and Care of Animals and the US Army Animal Care and Use Review Office. Four-month-old male athymic nude rats (NIH-Foxn1 rnu ) that lack a specific immune system were obtained from Charles River Laboratories (Wilmington, MA, USA). This animal model is commonly used for the study of xenografts, and we have previously demonstrated that nude rats develop fatty degeneration in a similar fashion to immune competent rats [8] . Rats were assigned to either serve as vehicle-treated controls or receive injections of SVFCs at a dose of either 3×10 5 cells or 3×10 6 cells in a randomized fashion.
Surgery Bilateral, chronic full-thickness supraspinatus tears and subsequent repairs after a period of 28 days were performed using sterile technique in a laminar flow hood [1, 9] . Post-operative care, antibiotics and analgesic medications were administered as described [1] . After the torn tendon was repaired, intramuscular injections of SVFCs that were isolated as described below and suspended in a vehicle of Lactated Ringers solution or vehicle alone were performed using a 25-gauge needle. Injections occurred in the proximal, middle and distal thirds of the supraspinatus muscle. Fourteen days after repair surgery, rats were anaethetised with sodium pentobarbital (50 mg/kg), and supraspinatus muscles were harvested and weighed. Permeabilised fibre contractility Single fiber contractility was performed as previously described [8, 9] . The cross sectional area (CSA) of fibers was measured, and maximum isometric force (F o ) was elicited by immersing the fiber in a high calcium solution. Specific force (sF o ) was calculated by dividing F o by CSA. Ten to 20 fast fibres were tested from each muscle.
Genomic DNA content To determine the amount of human genomic DNA (gDNA) that was present in treated muscles, we designed human-and rat-specific primers against the β2-microglobulin gene and then measured the abundance of human gDNA relative to rat gDNA in treated supraspinatus muscles using a quantitative PCR (qPCR) based detection strategy modified from Becker [12] . DNA was isolated from samples using a DNeasy kit (Qiagen, Valencia, CA, USA) per the manufacturer's instructions, and treated with RNase A (Qiagen). DNA concentration was obtained using a NanoDrop ND2000 (ThermoFisher, Rockford, IL, USA), and all samples had A 260 /A 280 ratios>1.8. qPCR was conducted using 300 ng of total DNA along with primers we designed to recognize either human specific β2-microglobulin or rat specific β2-microglobulin (Table 1 and Fig. 1a ) and Ssofast qPCR reagents (BioRad, Hercules, CA, USA) in a CFX96 optical thermal cycler system (BioRad). The presence of single amplicons was verified using melt-curve analysis, and electrophoretic separation of PCR reactions in a 2 % agarose gel that was stained with ethidium bromide (Sigma Aldrich, St. Louis, MO, USA) and visualized in a ChemiDoc system (BioRad).
Histology Supraspinatus muscles were cryosectioned at a thickness of 10 μm, and slides were fixed with 4 % paraformaldehyde and permeabilized with 0.1 % Triton X-100. To detect the presence of human protein or gDNA, slides were incubated with antibodies against the human cell membrane protein β2-microglobulin (AbCam, Cambridge, MA, USA) or biotinylated probes against Alu sequences found only in the human genome. Muscle fiber membranes were identified using antibodies against dystrophin (DSHB, Iowa City, IA, USA). Cell nuclei were labeled with DAPI (Sigma Aldrich). Primary antibodies and probes were detected with highly cross-adsorbed secondary antibodies, avidin conjugated to AlexaFluor probes or a tyramide amplification kit (Life Technologies, Carlsbad, CA, USA). Images were obtained using an Axioplan 2 (Zeiss, Jena, Germany) microscope equipped with AxioCam (Zeiss) cameras.
Hydroxyproline content Measurement of hydroxyproline, which is commonly used as a marker of collagen content, was performed using a colorimetric assay as previously described [9] and normalized to the dry mass of the muscle tissue.
Lipid analysis Lipid extraction from muscle tissue and analysis was performed as described [9] . Samples and known lipid standards were spotted on HPTLC plates (EMD Millipore, Billerica, MA, USA), developed to separate lipid species and visualized with Rhodamine 6G in a ChemiDoc (BioRad).
Statistical analysis Data are presented as mean±SE. Differences between groups were tested using a one-way ANOVA (α=0.05) followed by Fisher's LSD post-hoc sorting, with the exception of percent human DNA, which was measured using t-tests (α=0.05). All analyses were performed in Prism 6.0 (GraphPad, La Jolla, CA).
Results
Two weeks following the repair of torn rotator cuff muscles, there were no changes in supraspinatus mass between groups ( Table 2) . We evaluated changes in functional muscle cell contractility, and no significant differences in muscle fibre Fig. 1 Human DNA content, immunohistochemistry, and in situ hybridization. a Agarose gels demonstrating species specificity for primers designed for human specific β2-microglobulin (hB2M) and rat specific β2-microglobulin (rB2M) using DNA isolated from a pure population of human SVFCs or from rat EDL muscle. b Percent human DNA in torn rotator cuff muscles from control (N=10), 3×10 5 SVFC (N=8), and 3×10 6 SVFC (N=8) groups. Values are mean±SE. Differences between 3×10
5 SVFC and 3×10 6 SVFC were evaluated using a t-test (α = 0.05). *Significantly different (P < 0.05). Representative immunohistochemistry human β2-microglobulin staining (blue, nuclei; red, human β2M) of (c) and human Alu probe staining (blue, nuclei; red, dystrophin; white, human Alu probe) (d) CSA or F o were observed ( Table 2 ). While no statistically significant changes were observed, compared to controls there was a statistical trend in the 3×10 6 group for a 12 % decrease in fiber CSA (p=0.07) and a 25 % increase sF o production (p=0.07, Table 2 ).
We next measured the abundance of human DNA in samples. There was a dose-dependent increase from 0.2 % human DNA in the 3×10 5 SVFC group to 8.7 % human DNA in the 3×10 6 SVFC group (Fig. 1b) . As the 3×10 6 SVFC group demonstrated a high level of human DNA content, we then evaluated the localization of human protein and DNA in histological sections of muscle. Using an antibody that specifically detects the human β2-microglobulin membrane protein, we observed the presence of this protein on the surface of treated muscle fibres, and in cells located in a position under the muscle fibre basal lamina (Fig. 1c) . To further verify the presence of human cells, we used probes against human Alu DNA sequences, and human nuclei were observed in and around muscle fibre (Fig. 1d) .
We next evaluated quantitative changes in collagen and lipid content between groups. There was an approximately 40 % reduction in hydroxyproline content in the treated samples compared to controls, but there was no dose dependent change in hydroxyproline content between the 3×10 5 cell group and the 3×10 6 cell group (Fig. 2a) . A grossly apparent reduction in ECM abundance was also apparent in histological sections (Fig. 2b) . Despite the reduction in fibrosis, there were no differences between groups for triglyceride levels, nor were any differences observed for phospholipid levels, which serve as a loading control for total lipid measurements (Fig. 3) .
Discussion
Chronic rotator cuff tears are one of the most frequent and debilitating injuries of the upper extremity. Because SVFC treatment has been beneficial in other models of muscle injury [7] , we sought to assess the effect of SVFC treatment on rotator cuff regeneration following chronic tear. To our knowledge, this was the first study to evaluate SVFC transplantation on muscle function and fibrosis following chronic rotator cuff tear and repair. Using a fully automated point of care cell isolation system, we demonstrated that human SVFCs can be stably introduced into torn rotator cuff muscles of immunodeficient rats, resulting in the production of functional human protein and a significant reduction in fibrosis. Chronic fibrosis after rotator cuff tear leads to increased muscle stiffness and tension at the repair site [4] , and along with the poor quality of the muscle due to atrophy and fatty infiltration [8] , the potential for healing of torn rotator cuff muscles even after repair remains low. SVFC transplantation has been associated with a reduction in fibrosis and improved regeneration in other tissue injury and disease models, such as liver injury [13] , Peyronie's disease [14] , myocardial infarctions [15] , and Dupuytren's disease [16] , and supports our finding of reduced fibrosis after rotator cuff tear. The mechanism behind the reduction in fibrosis following SVFC treatment in various tissues is unclear. SVFCs may act by inhibiting collagen synthesis and reducing the proliferation of fibroblasts either directly [16] or indirectly through the regulation of macrophages [17] . Combined with data from Oh et al. [18] that found SVFCs augment tendon to bone healing following rotator cuff Values are mean±SE. Differences between groups were tested using a one-way ANOVA (α=0.05) followed by Fisher's LSD post-hoc sorting Fig. 2 Hydroxyproline content and ECM accumulation. a Hydroxyproline content from control (N=10), 3×10 5 SVFC (N=8), and 3×10 6 SVFC (N=8) groups. Values are mean±SE. Differences between groups were tested using a one-way ANOVA (α=0.05) followed by Fisher's LSD post-hoc sorting. *Significantly different from control group (P<0.05). b Representative images stained with DAPI (blue, nuclei) and WGA (green, ECM) from control, 3×10
5 SVFC, and 3× 10 6 SVFC groups repair, SVFC treatment in chronically torn rotator cuff muscles of patients may improve muscle quality, reduce fibrosis, and lead to a more stable repair. Previous work in dystrophin-deficient mdx mice has shown that human adipose derived MSCs are able to differentiate into the myogenic lineage, and fuse with existing mouse muscle fibres in vivo to restore dystrophin expression and ameliorate the disease phenotype [19, 20] . The current work demonstrates that human SVFCs, when injected into injured rat muscle tissue, are also able to differentiate into the myogenic lineage and enhance the regeneration of torn rotator cuff muscles. Despite the location of SVFCs within adipose tissue, we did not find any human β2M or Alu+adipocytes within torn rotator cuff muscles, and we did not detect any changes in total lipid content between groups. The abundance of total triglyceride content of muscles in the present study is consistent with levels observed in previous rat studies [8, 9] . Although there were no differences between groups with regards to lipid content, there was a trend towards an improvement in muscle fiber sF o production in the 3×10 6 cell group, indicating that the treatment with SVFCs did not exacerbate fatty degeneration within these muscles. Overall, while SVFC therapy did not have an impact on force generating capacity or lipid content, given the profound impact on fibrosis, these results suggest that SVFC therapy has the potential to be both safe and successful when used to treat patients with chronic, full-thickness rotator cuff tears.
This study has many limitations. Although T-cell deficient rats develop fatty degeneration in a similar fashion to immunocompetent rats [8] , no rat model develops the extent of fatty degeneration as seen in humans [21] [22] [23] . We chose a single time point of two weeks following repair and injection for our measurements and did not assess muscle function or SVFC viability past this time. We also used a single subject and did not assess the activity of SVFCs from multiple subjects. Despite these limitations, we believe this study provided important insight into the practicality and efficacy of SVFC therapy on the regeneration of chronic rotator cuff tears.
Using bone marrow aspirate as a stem cell source, the potential for MSCs to augment rotator cuff repair has shown tremendous promise in improving outcomes and reducing re-ruptures in patients [24, 25] . In the present study, we used a fully automated cell isolation system and were able to quickly obtain an enriched population of SVFCs with no postisolation treatment or expansion in culture. These cells were directly injected into chronically torn rotator cuff muscles, and two weeks following injection we demonstrated that rotator cuff muscles contained human DNA, functional human protein and had a striking reduction in fibrosis. This cell isolation approach is likely to be practical as a point-of-care system in an operating suite as well. For most patients, 60 cc of abdominal fat can be harvested with little donor site morbidity. After harvesting the fat tissue via liposuction and repositioning of the patient, SVFCs can be isolated in about an hour which would allow the surgeon to begin the repair procedure while the cells are being sorted and prepared for injection. While there is encouraging long-term results from patients who received bone marrow MSC augmentation at the time of rotator cuff repair [24] , the results from the present study suggest that SVFCs might also have the potential to enhance the recovery of chronic rotator cuff tears.
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